Submission Provisions for Registration Documents under NT 37 Article 5.2

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Article 5.2 of NT 37 Versión 5-2016 establishes six general provisions for the submission of registration documents: originals may be replaced by notarially authenticated photocopies; documents must be valid on the day of submission at the window; all documents must be clearly legible; foreign-issued documents must satisfy Guatemalan statutory requirements; documents not in Spanish must be translated by a sworn translator authorised in Guatemala; and documents that carry no stated validity period are accepted for a maximum of 2 years from their date of issue. These six provisions apply across the entire dossier rather than to any single item, which means every document in the file must be screened against all six tests before the submission date is fixed. Treating the list as a single gatekeeping rule set keeps preparation predictable and prevents late-stage surprises at the window.

  • Originals can be substituted by notarially authenticated photocopies under Article 5.2.1.
  • Validity is judged on the day the document is handed in at the submission window, not on the application date.
  • Legibility is a formal requirement applicable to every page of every document.
  • Foreign documents must satisfy both Guatemalan statutory requirements and the requirements of the competent authority.
  • Translations must be produced by a sworn translator authorised in the Republic of Guatemala.
  • Documents without a stated validity period are accepted for up to 2 years from issue.

2. Legal basis

The table below sets out the six provisions in the order in which the standard presents them, each with its governing clause. The wording of each provision is general in character, so its effect reaches beyond the three documents named in the opening of Article 5.2 to the dossier as a whole.

Item no.ProvisionClause
1What the clause calls an original may be replaced by a notarially authenticated photocopyArticle 5.2.1
2Documents must be valid on the day of submission at the windowArticle 5.2.2
3All documents must be clearly legibleArticle 5.2.3
4Documents issued abroad must satisfy the statutory requirements of Guatemala and the requirements of the competent authorityArticle 5.2.4
5Documents not in Spanish must be translated by a sworn translator authorised in the Republic of GuatemalaArticle 5.2.5
6Documents without a stated validity period are accepted for a maximum of 2 years from the date of issueArticle 5.2.6

Scope of application: the opening of Article 5.2 names the original certificate of free sale, the original good manufacturing practices certificate and the manufacturer’s letter of authorisation as the documents it addresses, but the six provisions are drafted in general terms and are applied in practice to the entire dossier. For reagents, the corresponding provisions are found in Articles 4.2.1 to 4.2.5 of NT-40.

3. Expert insights

Insight one: Article 5.2.1 materially softens the original-document requirement. The clause allows an original to be replaced by a “fotocopia legalizada notarialmente” — a notarially authenticated photocopy. This matters greatly for manufacturers who file in several countries, because a single original no longer has to circulate between jurisdictions; an authenticated copy can serve in each one. The authentication step, however, cannot be skipped. A photocopy that is clean and readable but not legalised fails the provision, so the notarial or consular chain of authentication must be planned as part of the document production timeline rather than treated as an afterthought at the window.

Insight two: the reference point of Article 5.2.2 is the day of submission at the window. It is not the date the application was signed, nor the date of technical review, but the day on which the document is physically handed in at the window. This has direct scheduling consequences: a document must not be presented on the last day of its validity, because if the window raises a request for correction and the dossier must be re-submitted, the document will already have expired by the time it returns. Building margin into the submission plan is therefore not caution but necessity, since the operative date is outside the applicant’s control once the file is queued.

Insight three: Article 5.2.6 sets a hard ceiling for documents without a validity period. Letters of authorisation frequently omit any expiry date, and the authority handles this with a fixed rule: such documents are accepted for a maximum of 2 years from their date of issue. This converts what would otherwise be a grey zone into a determinate calculation, and it makes the issue date of the letter of authorisation a plannable scheduling variable. A letter issued too early relative to the expected submission window will age out before the file is complete, forcing the manufacturer to obtain a fresh original and repeat the authentication process.

Insight four: Articles 5.2.4 and 5.2.5 are two independent obligations. One governs legal effect — foreign documents need authentication — and the other governs language — translation by a locally authorised sworn translator. Apostille or consular legalisation and sworn translation correspond to these two provisions respectively, and completing one does not discharge the other. A document can be perfectly legalised yet remain inadmissible because it has not been translated, and vice versa. Running the two tracks in parallel, and verifying legibility once both are complete, is the practical reading of this pair of clauses.

4. Practical recommendations

  • Maintain a document validity tracker that back-calculates the required issue date of every document from the window submission day.
  • For documents needed in several countries, substitute notarially authenticated photocopies for originals to avoid circulating the original.
  • Keep a validity margin of at least 3 months on time-limited documents to absorb correction and re-submission cycles.
  • For documents without a validity period, principally letters of authorisation, back-plan the issue date against the 2-year ceiling from issue.
  • Advance authentication and translation as two parallel workstreams that do not substitute for each other, and re-check legibility once both are complete.

5. Verification checklist

  • □ Originals or their notarially authenticated photocopies are complete for all required documents
  • □ Every document remains valid on the day of submission at the window
  • □ All documents are clearly legible throughout
  • □ Foreign-issued documents have satisfied Guatemalan statutory requirements
  • □ Documents not in Spanish have been translated by a locally authorised sworn translator
  • □ No document without a stated validity period exceeds the 2-year ceiling
  • □ The validity tracker has been built with the window submission day as its reference point

Regulatory information verified as of October 29, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail